Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$1.82−0.02 (-1.09%)
Close on Nov 17, 2026Market cap $565.71MP/E –Yield 0.00%
Pacific Biosciences of California operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Pacific Biosciences of California's operating cash flow for the twelve months ending Jun 30, 2026 was -$118.05M. For fiscal 2025 it was -$111.21M. The highest annual figure on record is $19.50M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$111.21M | – |
| FY2024 | Dec 31, 2024 | -$206.06M | – |
| FY2023 | Dec 31, 2023 | -$259.17M | – |
| FY2022 | Dec 31, 2022 | -$263.21M | – |
| FY2021 | Dec 31, 2021 | -$111.18M | -670.1% |
| FY2020 | Dec 31, 2020 | $19.50M | – |
| FY2019 | Dec 31, 2019 | -$78.31M | – |
| FY2018 | Dec 31, 2018 | -$66.43M | – |
| FY2017 | Dec 31, 2017 | -$67.52M | – |
| FY2016 | Dec 31, 2016 | -$67.93M | – |
| FY2015 | Dec 31, 2015 | -$47.89M | – |
| FY2014 | Dec 31, 2014 | -$51.47M | – |
| FY2013 | Dec 31, 2013 | -$29.83M | – |
| FY2012 | Dec 31, 2012 | -$76.82M | – |
| FY2011 | Dec 31, 2011 | -$102.97M | – |
| FY2010 | Dec 31, 2010 | -$122.00M | – |
| FY2009 | Dec 31, 2009 | -$74.84M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$35.58M | – |
| Q1 FY2026 | Mar 31, 2026 | -$44.69M | – |
| Q4 FY2025 | Dec 31, 2025 | -$19.07M | – |
| Q3 FY2025 | Sep 30, 2025 | -$18.71M | – |
| Q2 FY2025 | Jun 30, 2025 | -$29.38M | – |
| Q1 FY2025 | Mar 31, 2025 | -$44.06M | – |
| Q4 FY2024 | Dec 31, 2024 | -$30.65M | – |
| Q3 FY2024 | Sep 30, 2024 | -$45.46M | – |
| Q2 FY2024 | Jun 30, 2024 | -$54.26M | – |
| Q1 FY2024 | Mar 31, 2024 | -$75.68M | – |
| Q4 FY2023 | Dec 31, 2023 | -$57.56M | – |
| Q3 FY2023 | Sep 30, 2023 | -$65.18M | – |
| Q2 FY2023 | Jun 30, 2023 | -$41.74M | – |
| Q1 FY2023 | Mar 31, 2023 | -$94.69M | – |
| Q4 FY2022 | Dec 31, 2022 | -$60.57M | – |
| Q3 FY2022 | Sep 30, 2022 | -$63.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$60.56M | – |
| Q1 FY2022 | Mar 31, 2022 | -$79.03M | – |
| Q4 FY2021 | Dec 31, 2021 | -$31.71M | – |
| Q3 FY2021 | Sep 30, 2021 | -$40.66M | – |
| Q2 FY2021 | Jun 30, 2021 | -$15.71M | – |
| Q1 FY2021 | Mar 31, 2021 | -$23.10M | -130.7% |
| Q4 FY2020 | Dec 31, 2020 | -$14.26M | – |
| Q3 FY2020 | Sep 30, 2020 | -$17.81M | – |
| Q2 FY2020 | Jun 30, 2020 | -$23.79M | – |
| Q1 FY2020 | Mar 31, 2020 | $75.36M | – |
| Q4 FY2019 | Dec 31, 2019 | -$18.18M | – |
| Q3 FY2019 | Sep 30, 2019 | -$17.26M | – |
| Q2 FY2019 | Jun 30, 2019 | -$17.56M | – |
| Q1 FY2019 | Mar 31, 2019 | -$25.31M | – |
| Q4 FY2018 | Dec 31, 2018 | -$18.99M | – |
| Q3 FY2018 | Sep 30, 2018 | -$14.18M | – |
| Q2 FY2018 | Jun 30, 2018 | -$14.50M | – |
| Q1 FY2018 | Mar 31, 2018 | -$18.77M | – |
| Q4 FY2017 | Dec 31, 2017 | -$20.20M | – |
| Q3 FY2017 | Sep 30, 2017 | -$17.84M | – |
| Q2 FY2017 | Jun 30, 2017 | -$12.81M | – |
| Q1 FY2017 | Mar 31, 2017 | -$16.67M | – |
| Q4 FY2016 | Dec 31, 2016 | -$12.90M | – |
| Q3 FY2016 | Sep 30, 2016 | -$15.88M | – |
See a number that looks wrong?